T Helper 1 Cytokines and Their Relationship with Beta Cell Function in Type 1 Diabetes

被引:0
作者
Tamer, Gonca [1 ]
Isbilen Basok, Banu [2 ]
Dogan, Burcu [3 ]
Telci Caklili, Ozge [4 ]
Kostek, Osman [5 ]
机构
[1] Istanbul Medeniyet Univ, Div Endocrinol & Metab, Goztepe Training & Res Hosp, Istanbul, Turkey
[2] Univ Hlth Sci, Izmir Tepecik Training & Res Hosp, Dept Biochem, Izmir, Turkey
[3] Istanbul Medeniyet Univ, Dept Family Med, Goztepe Training & Res Hosp, Istanbul, Turkey
[4] Istanbul Univ, Dept Endocrinol & Metab, Fac Med, Istanbul, Turkey
[5] Trakya Univ, Dept Oncol, Fac Med, Edirne, Turkey
关键词
Type; 1; diabetes; IFN-gamma; IL-2; TNF-alpha; T helper-1 cell; INTERFERON-GAMMA; GLYCEMIC CONTROL; INFLAMMATION; ASSOCIATION; PATHOGENESIS; INSULITIS; MELLITUS; CHILDREN; AGE;
D O I
10.25179/tjem.2019-71070
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: In type 1 diabetes (T1D), T helper (Th) 1 cells affect beta cell functions significantly. This study aims to explore the association between serum levels of Th1 cytokines [interferon-gamma (IFN-gamma), interleukin (IL)-2 and tumor necrosis factor-alpha (TNF-alpha)] and beta cell function in T1D. Material and Methods: The study included 110 patients with T1D (TIDPs) and 31 healthy controls. The beta cell functions in T1DPS were assessed by calculating mixed-meal stimulated C-peptide levels. T1DPs were categorized into three groups depending on results of this test (1a-lowest, 1b, 1c-highest). Cytokine levels, IFN-gamma/IL-2, and TNF-alpha/IL-2 ratios in T1DPs were compared with that in controls. Correlation analysis between cytokine levels and diabetes-related parameters was then carried out. Results: IFN-gamma, TNF-alpha, IL-2 levels, and TNF-alpha/IL-2 of T1DPs were higher (p=0.02, p=0.01, p=0.008, and p=0.01, respectively) than that of controls. The highest IFN-gamma/IL-2 and TNF-alpha/IL-2 ratios were observed in group 1b (p=0.03 and p=0.04, respectively) while the lowest IFN-gamma/IL-2 and TNF-alpha/IL-2 ratios were observed in group 1a (p=0.03 and p=0.04, respectively). The TNF-alpha levels were found to be negatively correlated with fasting glucose levels (r(2) =-0.003, p=0.031). However, after adjustment for age and gender, this correlation diminished (r(2) =-0.028, p=0.076). Conclusion: IFN-gamma, IL-2, and TNF-alpha may exhibit a triggering role in the pathogenesis of T1D. IFN-gamma/IL-2 and TNF-alpha/IL-2 ratios possibly have more significant roles in the progression of beta cell dysfunction than other cytokines.
引用
收藏
页码:177 / 183
页数:7
相关论文
共 50 条
  • [31] Insulin-like growth factor-1 cytokines cross-talk in type 1 diabetes mellitus: Relationship to microvascular complications and bone mineral density
    AboElAsrar, Mohammed A.
    Elbarbary, Nancy S.
    Elshennawy, Dina E.
    Omar, Amin M.
    [J]. CYTOKINE, 2012, 59 (01) : 86 - 93
  • [32] Abnormal cannabidiol ameliorates inflammation preserving pancreatic beta cells in mouse models of experimental type 1 diabetes and beta cell damage
    Gonzalez-Mariscal, Isabel
    Pozo-Morales, Macarena
    Romero-Zerbo, Silvana Y.
    Espinosa-Jimenez, Vanesa
    Escamilla-Sanchez, Alejandro
    Sanchez-Salido, Lourdes
    Cobo-Vuilleumier, Nadia
    Gauthier, Benoit R.
    Bermudez-Silva, Francisco J.
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 145
  • [33] Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population
    Hu, C.
    Wang, C.
    Zhang, R.
    Ma, X.
    Wang, J.
    Lu, J.
    Qin, W.
    Bao, Y.
    Xiang, K.
    Jia, W.
    [J]. DIABETOLOGIA, 2009, 52 (07) : 1322 - 1325
  • [34] Combination therapy for preservation of beta cell function in Type 1 diabetes: New attitudes and strategies are needed!
    Ludvigsson, Johnny
    [J]. IMMUNOLOGY LETTERS, 2014, 159 (1-2) : 30 - 35
  • [35] New therapies aimed at the preservation or restoration of beta cell function in type 1 diabetes
    Keymeulen, B.
    [J]. ACTA CLINICA BELGICA, 2006, 61 (05) : 275 - 285
  • [36] Pathogenic T helper type 17 cells contribute to type 1 diabetes independently of interleukin-22
    Bellemore, S. M.
    Nikoopour, E.
    Krougly, O.
    Lee-Chan, E.
    Fouser, L. A.
    Singh, B.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 183 (03) : 380 - 388
  • [37] An Arab registry for type 1 diabetes: global benefits for type 1 diabetes patients
    Zayed, Hatem
    Ouhtit, Allal
    El Bekay, Rajaa
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (10) : 1681 - 1684
  • [38] Humanized Mice for the Study of Type 1 Diabetes and Beta Cell Function
    King, Marie
    Pearson, Todd
    Rossini, Aldo A.
    Shultz, Leonard D.
    Greiner, Dale L.
    [J]. IMMUNOLOGY OF DIABETES V: FROM BENCH TO BEDSIDE, 2008, 1150 : 46 - 53
  • [39] T Helper 22 Pathway Evaluation in Type 1 Diabetes and Its Complications
    Akbari, Hossein
    Ghardashi, Mostafa
    Soleimani, Alireza
    Mohammadi, Hanieh
    Nikoueinejad, Hassan
    [J]. IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2018, 17 (03) : 258 - 264
  • [40] Assessment of beta cell function in subjects with newly diagnosed type 2 diabetes
    Cernea, Simona
    Hutanu, Adina
    Coros, Ligia
    Dobreanu, Minodora
    [J]. REVISTA ROMANA DE MEDICINA DE LABORATOR, 2013, 21 (2-4): : 145 - 160